News & Updates
Filter by Specialty:
Record-high rise in alcohol-related hepatitis during pandemic a cause for alarm
Cases of severe alcohol-related hepatitis requiring inpatient management has dramatically increased during the COVID-19 pandemic, particularly in patients aged <40 years and in women, a study has found.
Record-high rise in alcohol-related hepatitis during pandemic a cause for alarm
12 Mar 2022
Empagliflozin lowers blood pressure in T2D
Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.
Empagliflozin lowers blood pressure in T2D
12 Mar 2022
Upadacitinib shows promise for long-term AD treatment
Upadacitinib with topical corticosteroids shows good long-term efficacy and safety in patients with moderate-to-severe atopic dermatitis (AD), reports a recent follow-up analysis to the AD Up study.
Upadacitinib shows promise for long-term AD treatment
12 Mar 2022
Anthropometric measurements at birth do not affect response to obesity treatment
While neonatal anthropometric measures are related to the degree of obesity in childhood, it does not seem to affect response to multidisciplinary treatment to childhood obesity, a recent study has found.
